Literature DB >> 24375039

Distribution of CXCR4 and γ-catenin expression pattern in breast cancer subtypes and their relationship to axillary nodal involvement.

O N Sivrikoz1, L Doganay, U K Sivrikoz, S Karaarslan, S M Sanal.   

Abstract

Chemokine receptor 4 (CXCR4) and γ-catenin are known to play an important role in development of metastasis in breast cancer. However, there is not enough information about these biological markers' distribution in different breast cancer subtypes, or their relationship to lymph node metastases in each subtype. In this study, staining characteristics of CXCR4 and γ-catenin were analyzed in each breast cancer subtype and their relationship to lymph node involvement explored. There was a statistically significant relationship between CXCR4 and certain tumor subtypes (p < 0.05). Basal-like and HER2 enriched tumors showed strong CXCR4 positivity (45.7%). Furthermore, a significant correlation was discovered between CXCR4 positivity and lymph node involvement (p < 0.05). Among tumor subtypes staining positively with CXCR4, 80% of basal-like, 90% of HER2 enriched, and 78.5% of luminal A showed axillary lymph node involvement. In general, there was a positive relationship between histological grade and CXCR4 expression (p = 0.004). A statistically significant correlation existed between HER2 positivity and γ-catenin expression (p < 0.05). Basal-like and HER2 enriched breast cancer subtypes express CXCR4 staining more often than the other subtypes. Additionally, there is also a positive relationship between lymph node involvement and CXCR4 staining of these subtypes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24375039     DOI: 10.5114/pjp.2013.39333

Source DB:  PubMed          Journal:  Pol J Pathol        ISSN: 1233-9687            Impact factor:   1.072


  7 in total

1.  CXCL12 chemokine and CXCR4 receptor: association with susceptibility and prognostic markers in triple negative breast cancer.

Authors:  Alda Losi Guembarovski; Roberta Losi Guembarovski; Bruna Karina Banin Hirata; Glauco Akelinghton Freire Vitiello; Karen Mayumi Suzuki; Mayara Tiemi Enokida; Maria Angelica Ehara Watanabe; Edna Maria Vissoci Reiche
Journal:  Mol Biol Rep       Date:  2018-06-20       Impact factor: 2.316

2.  CXCL12 Retargeting of an Oncolytic Adenovirus Vector to the Chemokine CXCR4 and CXCR7 Receptors in Breast Cancer.

Authors:  Samia M O'Bryan; J Michael Mathis
Journal:  J Cancer Ther       Date:  2021-06

Review 3.  Immunohistochemical expression of CXCR4 on breast cancer and its clinical significance.

Authors:  Marina Okuyama Kishima; Carlos Eduardo Coral de Oliveira; Bruna Karina Banin-Hirata; Roberta Losi-Guembarovski; Karen Brajão de Oliveira; Marla Karine Amarante; Maria Angelica Ehara Watanabe
Journal:  Anal Cell Pathol (Amst)       Date:  2015-06-16       Impact factor: 2.916

4.  CCR9/CCL25 expression in non-small cell lung cancer correlates with aggressive disease and mediates key steps of metastasis.

Authors:  Pranav Gupta; Praveen K Sharma; Hina Mir; Rajesh Singh; Nalinaksha Singh; Goetz H Kloecker; James W Lillard; Shailesh Singh
Journal:  Oncotarget       Date:  2014-10-30

5.  Serum SDF-1 levels are a reliable diagnostic marker of feline mammary carcinoma, discriminating HER2-overexpressing tumors from other subtypes.

Authors:  Cláudia S Marques; Maria Soares; Ana Santos; Jorge Correia; Fernando Ferreira
Journal:  Oncotarget       Date:  2017-11-11

6.  Circulating tumor cell clusters-associated gene plakoglobin is a significant prognostic predictor in patients with breast cancer.

Authors:  Wataru Goto; Shinichiro Kashiwagi; Yuka Asano; Koji Takada; Katsuyuki Takahashi; Takaharu Hatano; Tsutomu Takashima; Shuhei Tomita; Hisashi Motomura; Masahiko Ohsawa; Kosei Hirakawa; Masaichi Ohira
Journal:  Biomark Res       Date:  2017-05-12

7.  Genetic Polymorphism and Expression of CXCR4 in Breast Cancer.

Authors:  Marina Okuyama Kishima; Karen Brajão de Oliveira; Carolina Batista Ariza; Carlos Eduardo Coral de Oliveira; Roberta Losi Guembarovski; Bruna Karina Banin Hirata; Felipe Campos de Almeida; Glauco Akelinghton Freire Vitiello; Kleber Paiva Trugilo; Alda Fiorina Maria Losi Guembarovski; Walter Jorge Sobrinho; Clodoaldo Zago Campos; Maria Angelica Ehara Watanabe
Journal:  Anal Cell Pathol (Amst)       Date:  2015-10-20       Impact factor: 2.916

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.